TITLE

Niemann-Pick C1-Like 1 protein: Another target for treatment of dyslipidemia? Evidence from the Myocardial Infarction Genetic Consortium and IMPROVE-IT trials

AUTHOR(S)
Hassan, Mohamed
PUB. DATE
October 2014
SOURCE
Global Cardiology Science & Practice;2014, Vol. 2014 Issue 4, p179
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the findings of the Myocardial Infarction Genetic Consortium and Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) randomized controlled trials which emphasize the clinical benefit of Niemann-Pick C1-Like 1 (NPC1L1) protein in the treatment of dyslipidemia. An overview of the IMPROVE-IT study, which aims to investigate the benefit from adding ezetimibe to simvastatin therapy in reducing cardiovascular (CV) events, is also given.
ACCESSION #
102145930

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics